BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anondita Medicare IPO is Open!
Apply for the Anondita Medicare IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

523620

PHRMASI

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

PHAARMASIA LTD. Share Price Update

As of the latest trading session, PHAARMASIA LTD. share price is currently at ₹ 30.39, which is up by ₹ 0.55 from its previous closing. Today, the stock has fluctuated between ₹ 30.23 and ₹ 31.32. Over the past year, PHAARMASIA LTD. has achieved a return of -40.49 %. In the last month alone, the return has been -8.35 %. Read More...

Investment Returns

Over 1 Month -8.35% Over 3 Months -4.82% Over 6 Months -18.22% Over 1 Year -40.49%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

PHAARMASIA LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    20.80

  • P/E Ratio (TTM)

    -12.75

  • Beta

    0.55

  • Book Value / share

    6.58

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.27

info icon alternate text

PHAARMASIA LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 6.87
Operating Expense 6.88
Net Profit 0.27
Net Profit Margin (%) 3.93
Earnings Per Share (EPS) 0.40
EBITDA 0.39
Effective Tax Rate (%) 12.90
Particulars MAR 2025 (Values in Cr)
Revenue 5.43
Operating Expense 6.13
Net Profit -0.53
Net Profit Margin (%) -9.76
Earnings Per Share (EPS) -0.77
EBITDA -0.43
Effective Tax Rate (%) -1.96
Particulars DEC 2024 (Values in Cr)
Revenue 4.72
Operating Expense 5.60
Net Profit -0.70
Net Profit Margin (%) -14.83
Earnings Per Share (EPS) -1.02
EBITDA -0.60
Effective Tax Rate (%) -1.44
Particulars SEP 2024 (Values in Cr)
Revenue 5.93
Operating Expense 6.79
Net Profit -0.64
Net Profit Margin (%) -10.79
Earnings Per Share (EPS) -0.94
EBITDA -0.57
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 8.29
Operating Expense 8.19
Net Profit 0.28
Net Profit Margin (%) 3.37
Earnings Per Share (EPS) 0.40
EBITDA 0.33
Effective Tax Rate (%) -12.00
Particulars MAR 2025 (Values in Cr)
Revenue 24.37
Operating Expense 26.72
Net Profit -1.59
Net Profit Margin (%) -6.52
Earnings Per Share (EPS) -2.33
EBITDA -1.26
Effective Tax Rate (%) 0.62
Particulars MAR 2024 (Values in Cr)
Revenue 30.59
Operating Expense 31.80
Net Profit -0.52
Net Profit Margin (%) -1.69
Earnings Per Share (EPS) -0.76
EBITDA -0.16
Effective Tax Rate (%) 5.45
Particulars MAR 2023 (Values in Cr)
Revenue 27.49
Operating Expense 29.43
Net Profit -1.26
Net Profit Margin (%) -4.58
Earnings Per Share (EPS) -1.84
EBITDA -1.02
Effective Tax Rate (%) 11.88
Particulars MAR 2022 (Values in Cr)
Revenue 17.22
Operating Expense 19.24
Net Profit -1.55
Net Profit Margin (%) -9.00
Earnings Per Share (EPS) -2.27
EBITDA -1.27
Effective Tax Rate (%) 1.28
Particulars MAR 2021 (Values in Cr)
Revenue 19.90
Operating Expense 20.31
Net Profit 0.31
Net Profit Margin (%) 1.55
Earnings Per Share (EPS) 0.46
EBITDA 0.83
Effective Tax Rate (%) 35.41
Particulars MAR 2024 (Values in Cr)
Book Value / Share 8.87
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.03
EBITDA Margin -0.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 9.62
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.02
EBITDA Margin -3.75
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.45
ROE % -17.98
ROCE % -17.75
Total Debt to Total Equity 0.00
EBITDA Margin -7.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.79
ROE % 3.34
ROCE % 5.02
Total Debt to Total Equity 0.01
EBITDA Margin 5.10
Particulars MAR 2020 (Values in Cr)
Book Value / Share 13.43
ROE % 6.08
ROCE % 10.43
Total Debt to Total Equity 0.02
EBITDA Margin 7.02
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.63
Total Assets 31.44
Total Liabilities 31.44
Total Equity 10.29
Share Outstanding 6826960
Price to Book Ratio 3.28
Return on Assets (%) -1.64
Return on Capital (%) -5.03
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.69
Total Assets 28.42
Total Liabilities 28.42
Total Equity 10.80
Share Outstanding 6827000
Price to Book Ratio 2.43
Return on Assets (%) -4.43
Return on Capital (%) -11.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 21.20
Total Liabilities 21.20
Total Equity 12.05
Share Outstanding 6827000
Price to Book Ratio 2.70
Return on Assets (%) -7.29
Return on Capital (%) -12.8
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.38
Total Assets 21.91
Total Liabilities 21.91
Total Equity 13.65
Share Outstanding 6826960
Price to Book Ratio 1.80
Return on Assets (%) 1.42
Return on Capital (%) 2.28
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.15
Total Assets 33.59
Total Liabilities 33.59
Total Equity 13.40
Share Outstanding 6826960
Price to Book Ratio 1.04
Return on Assets (%) 1.60
Return on Capital (%) 4
Particulars MAR 2024 (Values in Cr)
Net Income -0.54
Cash from Operations 0.10
Cash from Investing 0.00
Cash from Financing -0.16
Net change in Cash -0.05
Free Cash Flow 0.13
Particulars MAR 2023 (Values in Cr)
Net Income -1.43
Cash from Operations 0.64
Cash from Investing -0.01
Cash from Financing -0.16
Net change in Cash 0.47
Free Cash Flow 0.67
Particulars MAR 2022 (Values in Cr)
Net Income -1.56
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash -0.16
Free Cash Flow 0.00
Particulars MAR 2021 (Values in Cr)
Net Income 0.47
Cash from Operations 0.49
Cash from Investing 0.00
Cash from Financing -0.02
Net change in Cash 0.22
Free Cash Flow 0.49
Particulars MAR 2020 (Values in Cr)
Net Income 0.96
Cash from Operations 0.33
Cash from Investing 0.00
Cash from Financing -0.11
Net change in Cash -0.03
Free Cash Flow 0.33
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 34.22 13.97 1.87 262.24 30.00 / 69.75
BLISS GVS PHARMA LTD 166.55 16.47 1.67 1757.06 105.05 / 190.65
CIPLA LTD 1545.85 23.16 4.00 124866.66 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 342.40 9.64 2.77 1007.72 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2785.40 49.83 24.18 47186.36 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 34.22 18.60 5.40 262.24 30.00 / 69.75
AMRUTAJAN HEALTH LTD 722.05 38.28 6.39 2087.49 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8450.65 99.90 27.42 21126.63 6222.35 / 10653.05
BLISS GVS PHARMA LTD 166.55 24.90 1.65 1757.06 105.05 / 190.65

PHAARMASIA LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
30.39 1.87 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 28.70
  • 26 Days 30.20
  • 10 Days 28.80
  • 50 Days 31.10
  • 12 Days 28.90
  • 100 Days 32.70
  • 20 Days 29.80
  • 200 Days 35.80
28.92 PIVOT

First Support

27.29

First Resistance

30.04

Second Support

26.17

Second Resistance

31.67

Third Support

24.54

Third Resistance

32.79

RSI

41.95

ADX

37.97

MACD

-1.49

Williams % R

-53.38

Commodity Channel Index (CCI)

-37.90

Date

2025-08-20

Week

159.00

Same Day

202.00

Month

870.00

1 Year

0.55

3 Year

0.26

Over 1 Month

-8.35%

down

Over 1 Year

-40.49%

down

Over 3 Months

-4.82%

down

Over 3 Years

5.85%

down

Over 6 Months

-18.22%

down

Over 5 Years

-2.19%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

PHAARMASIA LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

PHAARMASIA LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

PHAARMASIA LTD. Share Price

Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai. M/s Phaarmasia Limited Unit-II was established in 1993-94. The Company is engaged in manufacturing and marketing of Oral contraceptive tablets' with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports.

The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission. Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum.

During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR.

During past a few decades, Phaarmasia mastered and manufactured wide range of Pharmaceutical Formulations at a WHO-GMP
certified and ISO 9001-certified manufacturing facility.

Parent organization Indian Private
NSE symbol [-]
Founded 1981
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Phaarmasia Ltd?

Answer Field

Phaarmasia Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 30.39 as on Aug 22 2025 03:03 PM.

What is the Market Cap of Phaarmasia Ltd Share?

Answer Field

The market cap of Phaarmasia Ltd for NSE ₹ 0.00 & for BSE ₹ 20.80 as on Aug 22 2025 03:03 PM.

What is the 52 Week High and Low of Phaarmasia Ltd?

Answer Field

The 52 Week High and Low of Phaarmasia Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 64.53 and ₹ 23.60.

What is 1 year return for Phaarmasia Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Phaarmasia Ltd Share?

Answer Field

As on Aug 22 2025 03:03 PM the price-to-earnings (PE) ratio for Phaarmasia Ltd share is -12.75.

What is the PB ratio of Phaarmasia Ltd Share?

Answer Field

As on Aug 22 2025 03:03 PM, the price-to-book (PB) ratio for Phaarmasia Ltd share is 6.58.

How to Buy Phaarmasia Ltd Share?

Answer Field

You can trade in Phaarmasia Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Phaarmasia Ltd Share on Bajaj Broking App?

Answer Field

To buy Phaarmasia Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Phaarmasia Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91